Repertoire Partners’s Rentokil RTO Stock Holding History

Repertoire Partners’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,000	Closed	-$1.43M	–	17
2023 Q4	$1.43M	Buy	+50,000	New	+$1.47M	2.03%	10

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Repertoire Partners's RTO Position: Q1 2024 in Review

Repertoire Partners sold out of Rentokil (RTO) in Q1 2024, closing a stake of 50,000 shares — an estimated $1.43M sold.

Repertoire Partners first reported a position in RTO in Q4 2023 and held it in 1 quarter. The position peaked at $1.43M in Q4 2023. 228 funds tracked by Wall St. Rank hold RTO as of Q1 2024.

Repertoire Partners reported no remaining Rentokil position as of Q1 2024 after selling out during the quarter.
Repertoire Partners sold 50,000 Rentokil shares in Q1 2024, an estimated $1.43M.
Repertoire Partners first reported a position in Rentokil in Q4 2023 and held it in 1 quarter.
Repertoire Partners's Rentokil position peaked at $1.43M in Q4 2023.
228 funds tracked by Wall St. Rank held Rentokil as of Q1 2024.

Based on Repertoire Partners's 13F filing for Q1 2024, filed 15 May 2024.